(SHRM) – Globe Newswire
-
Champignon Provides Update on Disclosure Review
-
Champignon to Begin Offering Esketamine Treatment for Adults With Major Depressive Disorder at the Canadian Rapid Treatment Centre of Excellence
-
Champignon Announces Filing of Business Acquisition Reports and Appointment of Director
-
Champignon Provides Corporate Update
-
Champignon Announces Regulatory Review
-
REPEAT - Champignon’s Dr. McIntyre / Canadian Rapid Treatment Centre of Excellence (CRTCE) Published in Two Peer Reviewed Study Journals
-
Champignon’s Dr. Mcintyre / Canadian Rapid Treatment Centre of Excellence (CRTCE) Published in Two Peer Reviewed Study Journals
-
REPEAT - Champignon Provides Corporate Update; Announces Name Change, Rebranding and Planned Spin Out
-
Champignon Provides Corporate Update; Announces Name Change, Rebranding and Planned Spin Out
-
REPEAT - Champignon Identifies Synthetic Ketamine and Psilocybin/Psilicin Metabolite Targets; Selects Dalriada to Advance NCE IP Portfolio
-
Champignon Identifies Synthetic Ketamine and Psilocybin/Psilicin Metabolite Targets; Selects Dalriada to Advance NCE IP Portfolio
-
Champignon Announces Voluntary Share Lock-Up; Retains Gold Standard Media, LLC for Financial Marketing Services
-
REPEAT - Champignon Appoints Dr. Bill Wilkerson, Executive Chairman of Mental Health International to Board of Directors
-
Champignon Appoints Dr. Bill Wilkerson, Executive Chairman of Mental Health International to Board of Directors
-
REPEAT - Champignon Sponsors Non-profit Coalition, TheraPsil - Medical Psilocybin Access Project for Palliative Cancer Patients and Health Professionals
-
Champignon Sponsors Non-profit Coalition, TheraPsil - Medical Psilocybin Access Project for Palliative Cancer Patients and Health Professionals
-
Champignon Expands to U.S., To Acquire California Based Ketamine Centre – Wellness Clinic of Orange County
-
REPEAT - Champignon Appoints Dr. Roger McIntyre as Chief Executive Officer
-
Champignon Appoints Dr. Roger McIntyre as Chief Executive Officer
-
REPEAT - Champignon Appoints Pat McCutcheon to Board of Directors
-
Champignon Appoints Pat McCutcheon to Board of Directors
-
Champignon Forms North American Clinical Expansion Committee
-
Le traitement à base de kétamine de Champignon sera distribué par une importante chaîne de pharmacie canadienne et la compagnie annonce la clôture de la transaction d'AltMed
-
Champignon Ketamine Treatment to be Dispensed by Major Canadian Pharmacy Chain; Closes AltMed
-
Champignon Selected as Headline Partner for PSYCH: The Psychedelics Symposium at Prohibition Partners LIVE
-
Champignon Commences U.S. Trading on the OTCQB Venture Market Under Ticker Symbol “SHRMF”
-
REPEAT - Champignon Secures Stable Psilocybin Supply Under DEA Schedule I License for TBI/PTSD Studies at the University of Miami
-
Champignon Secures Stable Psilocybin Supply Under DEA Schedule I License for TBI/PTSD Studies at the University of Miami
-
Champignon Receives DTC Eligibility
-
REPEAT - Champignon Appoints Former President of Red Bull Canada to Special Advisory Committee
-
Champignon Appoints Former President of Red Bull Canada to Special Advisory Committee
-
REPEAT - CHAMPIGNON TO ACQUIRE ALTMED CAPITAL CORP., CONTRIBUTING HEALTH CANADA'S ONLY APPROVED PSYCHEDELIC MEDICINE CLINIC, SOPs FOR CLINICAL EXPANSION, EXISTING IP & MULTIPLE TRIALS
-
CHAMPIGNON TO ACQUIRE ALTMED CAPITAL CORP., CONTRIBUTING HEALTH CANADA'S ONLY APPROVED PSYCHEDELIC MEDICINE CLINIC, SOPs FOR CLINICAL EXPANSION, EXISTING IP & MULTIPLE TRIALS
-
Champignon Featured in Broadcast on Mental Health Options, Medical Mushrooms
-
Champignon Brands Spotlighted in Publication Discussing Potential of Mushrooms in Medicine
-
REPEAT - CHAMPIGNON APPOINTS UNIVERSITY OF TORONTO CLINICAL ADVISOR, PHARMACOGNOSIST TO SPECIAL ADVISORY COMMITTEE
-
CHAMPIGNON APPOINTS UNIVERSITY OF TORONTO CLINICAL ADVISOR, PHARMACOGNOSIST TO SPECIAL ADVISORY COMMITTEE
-
REPEAT - CHAMPIGNON EXPANDS PRECLINICAL PIPELINE WITH MEASURED PSILOCYBIN DOSAGES STUDIES AT UNIVERSITY OF MIAMI
-
CHAMPIGNON EXPANDS PRECLINICAL PIPELINE WITH MEASURED PSILOCYBIN DOSAGES STUDIES AT UNIVERSITY OF MIAMI
-
REPEAT - CHAMPIGNON BRANDS APPOINTS DR. JOSEPH GABRIELE, ERNST & YOUNG 2018 HEALTH CARE ENTREPRENEUR OF THE YEAR AND DELIVRA™ INVENTOR TO SPECIAL ADVISORY COMMITTEE
-
CHAMPIGNON BRANDS APPOINTS DR. JOSEPH GABRIELE, ERNST & YOUNG 2018 HEALTH CARE ENTREPRENEUR OF THE YEAR AND DELIVRA™ INVENTOR TO SPECIAL ADVISORY COMMITTEE
-
CHAMPIGNON BRANDS ANNOUNCES NORMAL COURSE ISSUER BID FOR COMMON SHARES OF THE CORPORATION
-
CHAMPIGNON BRANDS EXPANDS ALTERNATIVE MEDICINE IP PORTFOLIO WITH KETAMINE, ADAPTOGENIC DELIVERY SYSTEMS/FORMULATIONS
-
REPEAT: Champignon Brands to Acquire Craft Mushroom Cultivator
-
Champignon Brands to Acquire Craft Mushroom Cultivator
-
Champignon Brands Spotlighted in Publication Discussing Mushrooms in Medicine
-
Champignon Brands Completes Listing; to Form Special Advisory Committee
-
Champignon Brands Grants Stock Options
-
Champignon Brands Inc. Completes Initial Public Offering
Back to SHRM Stock Lookup